10 results

• Tandem Mobi Insulin Pump Recall Issued Following Multiple Serious Injuries

  April 23, 2026

  Martha Garcia

  The FDA has decided that a Tandem Mobi insulin pump device correction should be considered a Class I recall following multiple reports of serious patient injuries.

• Medtronic MiniMed Infusion Pump Recall Issued Over Risk of Hypo- or Hyperglycemic Reactions

  April 7, 2026

  Darian Hauf

  Federal health officials have announced a recall impacting more than half a million Medtronic MiniMed insulin pumps after the manufacturer identified a design flaw that may cause the devices to deliver too little or too much insulin.

• Medtronic Insulin Pump Air Pressure Issues Could Lead to Dangerously Low Blood Sugar Levels

  March 6, 2025

  Darian Hauf

  A medical device correction was issued by the manufacturer after identifying a design flaw that could lead to the insulin pumps malfunctioning during airplane flights.

• Vision Problems From Ozempic, Other GLP-1 Drugs May Result From Rapid Correction of Hyperglycemia: Study

  February 6, 2025

  Irvin Jackson

  A new study raises questions about whether Ozempic vision loss is caused by toxic ingredients in the drug, or the body's reaction to quickly dropping blood sugar levels.

• Medtronic MiniMed Insulin Pump Recall Over Battery Failure Risks

  October 7, 2024

  Irvin Jackson

  FDA has announced a class I recall impacting tens of thousands of Medtronic MiniMed insulin pumps, due to risks that the battery may deplete rapidly after the device has been dropped or physically impacted.

• Case Study Links Tepezza Side Effects to a Potential Risks for Diabetics

  October 4, 2023

  Irvin Jackson

  Tepezza side effects may cause a loss of glycemic control and increased risk of diabetic ketoacidosis, according to the findings of a new study.

• Tepezza Side Effects May Increase Risk of Hyperglycemia: Study

  November 29, 2022

  Irvin Jackson

  A new study found more than half of patients who took Tepezza experienced some form of hyperglycemia, which could be a particularly serious risk to patients with diabetes.

• Class Action Lawsuit Over Medtronic MiniMed Insulin Pumps Filed in Canada

  November 4, 2021

  Irvin Jackson

  Medtronic now faces a class action lawsuit in Canada over problems with its MiniMed 600 series insulin pumps, which have been subject to various recalls in recent years due to over- or underdelivering life-saving insulin.

• Lipitor, Zocor, Similar Cholesterol Drugs May Increase Risk of Diabetes Progression, Hyperglycemia: Study

  October 8, 2021

  Irvin Jackson

  The findings of a new study indicate taking cholesterol drugs like Lipitor and Zocor could speed up the progression of diabetes, increasing the risk of adverse health complications.

• Medtronic MiniMed Insulin Pump Lawsuit Alleges Device Failure Caused Hyperglycemic Episode

  August 10, 2021

  Irvin Jackson

  Medtronic faces a product liability over its recalled Minimed infusion pumps filed by a man who says defects in the device caused him to suffer hyperglycemia.